The Science and Medicine of Cancer
and Thrombosis Management

WebCAST

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Release Date:

June 30, 2009

Expiration Date:

June 30, 2011

Intended Audience:

The educational activity is designed for all physicians, academicians, researchers, investigators, and program directors from the fields of thrombosis, oncology, and haemostasis who manage patients with thrombosis-related disorders.

Registration:

Enrollment for this WebCAST is complimentary, and clinicians are invited to participate in this CME-certified WebCAST and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

The following program has been supported
by an independent medical educational grant
from Eisai, Inc.

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Massachusetts Medical School and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Policy on Faculty Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Program Faculty and Disclosures:

Craig M. Kessler, MD, MACP – Program Chairman
Professor of Medicine and Pathology
Georgetown University Medical Center
Lombardi Comprehensive Cancer Center
Director, Division of Coagulation
Washington, DC
Grant/Research Support: GlaxoSmithKline
Consultant: Sanofi-Aventis, Eisai Pharmaceuticals
Speaker’s Bureau: Sanofi-Aventis, GlaxoSmithKline

Frederick R. Rickles, MD, FACP
Center for Health Innovation
Public Sector Healthcare, Noblis
Professor of Medicine, Pediatrics and
Pharmacology and Physiology
The George Washington University
Washington, DC
Consultant: Genmab, Pharmacyclics, Pfizer, Eisai Pharmaceuticals, Sanofi-Aventis, Bristol-Myers Squibb
Speakers Bureau: Eisai Pharmaceuticals

Samuel Z. Goldhaber, MD
Professor of Medicine
Harvard Medical School
Director,Venous Thromboembolism
Research Group
Brigham and Women’s Hospital
Boston, MA
Grant/Research Support: Sanofi-Aventis, GSK
Consultant: Sanofi-Aventis, Eisai, Genentech, BMS, Possis, Medscape, Boehringer-Ingelheim

Educational Objectives:

As a result of participating in this program, clinicians from multiple disciplines, including oncology, hematology, surgical oncology, cancer supportive care, cancer nursing, internal medicine, clinical pharmacy, and related specialties will:

• Review recent trials, research, and expert analysis of issues focused on thrombosis and cancer, and apply the results and findings of these trials to clinical practice for cancer patients.

• Understand the scientific mechanisms, including the pathobiology of thrombosis-related complications, that explain the increased risk for thrombosis-related complications observed in patients with cancer.

• Learn how national guidelines for thrombosis prevention issued by ASCO, NCCN, and ACCP should impact management of patients with cancer.
  Learn specific strategies for risk-directed prophylaxis against VTE in at-risk patients with cancer.

• Learn which tumor types and therapeutic strategies place pa tients at higher risk for acquiring thrombosis-related complica tions and institute appropriate measures to reduce these risks.

• Learn how to assess and manage special needs of cancer patients at risk for VTE and how national guidelines issued by cancer-focused organizations can improve patient care in this population.

• Learn how to risk stratify patients undergoing cancer surgery, and implement guidelines recommended by 8th ACCP for pharmacologic and nonpharmacologic measures aimed at DVT prophylaxis.
  

Disclaimer:

Copyright © 2009 by CMEducation Resources, LLC and Pharmatecture, LLC All rights reserved. Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this WebCAST reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.

Content on this WebCAST is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this WebCAST is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This WebCAST is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This WebCAST is not intended for use by the layman.

Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, Pharmatecture, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © 2009 All rights reserved